2011
DOI: 10.4161/hv.7.5.14817
|View full text |Cite
|
Sign up to set email alerts
|

Considerations on the clinical application of the human papillomavirus vaccine in Spain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2012
2012
2015
2015

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 20 publications
0
2
0
1
Order By: Relevance
“…Three years later, in 2011, the impact of that document hadn´t been as successful as it was to thought it should have been. Because of persistent doubts about the usefulness of the recommendations on vaccination against HPV, its effectiveness and risk [17] a new consensus document focused on HPV vaccination was published in 2011 [18]. …”
Section: Discussionmentioning
confidence: 99%
“…Three years later, in 2011, the impact of that document hadn´t been as successful as it was to thought it should have been. Because of persistent doubts about the usefulness of the recommendations on vaccination against HPV, its effectiveness and risk [17] a new consensus document focused on HPV vaccination was published in 2011 [18]. …”
Section: Discussionmentioning
confidence: 99%
“…13,[15][16][17][18][19] Deterrent factors influencing personal decision-making in relation to HPV vaccination have been identified and analyzed and have highlighted, in particular, concerns surrounding vaccine effectiveness and an over-perception of the risk of side effects. [20][21][22] In the analysis of current opposition trends to systematic vaccination, arguments pertaining to the subjective and/or emotional realms allowing for a greater possibility of manipulation, rather than those of scientific evidence, were found. ReseARcH PAPeR 3 times or more.…”
mentioning
confidence: 99%
“…Cutáneotrópicos: epitelio escamoso VPHs 1,4,5,8,41,48,60,63 y 65 Mucosotrópicos: epitelio mucoso VPHs 6,11,13,16,18,26,30,31,33,34,35,39,42,45,51,52,53,54,55,56,58,59,64,66,67,68,69,70,73 Sin embargo, se observaron casos de afectación de ambos epitelios por el mismo virus HPV, por lo que se clasificaron posteriormente en función de su capacidad para producir verrugas en piel (HPV 1) o en el área anogenital (HPV 6, 16 y 18), pero también existían casos de HPV que ocasionaban lesiones en ambas localizaciones.…”
Section: Iii33-clasificación Del Hpvunclassified